摘要
目的探讨浸润性乳腺癌组织中Syk mRAN的表达及其临床意义。方法采用逆转录聚合酶链反应(RT-PCR)法检测30例乳腺癌患者瘤体及癌旁正常组织中Syk mRAN的含量,同时采用免疫组化SP法检测瘤体石蜡切片中ER、PR的定性表达情况。结果瘤体组织中Syk mRAN的表达水平明显低于癌旁正常组织(P<0.01),但与ER、PR以及临床分期、病理学分级、淋巴结转移等临床病理因素均无关(P>0.05)。结论Syk mRAN的异常表达与乳腺肿瘤的发生有关。
Objective To explore the clinical significance of Syk (splean tyrosine kinase) mRNA expression in invasive breast carcinoma tissues. Methods The contents of Syk mRNA in the breast cancer tissue and non-cancerous tissue were detected by RTPCR in 30 breast carcinoma patients, and ER and PR of the cancer tissue were examined by immunohistochemical SP method. Results There were significant differences in the expression of Syk mRNA between the malignant and non-cancerous breast tissues(P〈0.01 ), however, we did not find any correlation between reduction/loss of Syk mRNA expression in breast cancer tissue and clinicopathologic factors or other prognostic markers in our series study(P〈0.05). Conclusion The aberrant expression of Syk mRAN in breast probably plays an important role in the malignant growth of the cells.
出处
《肿瘤》
CAS
CSCD
北大核心
2005年第5期475-477,共3页
Tumor
基金
河北省科技攻关项目(编号:02276103D-18)